The Motivation for Alcohol Reward: Predictors of Progressive-Ratio Intravenous Alcohol Self-Administration in Humans
April 28th, 2022
This study aims to show that the Progressive-Ratio Computer-assisted Alcohol-Infusion System (CAIS) paradigm is a reliable and sensitive method that can be used to examine the motivating properties associated with alcohol self-administration in humans.
This progressive ratio method can be used to examine the motivating properties associated with alcohol self-administration and capture the sources of variability of this behavior in humans. To assess risky patterns of alcohol consumption and relate them to risk factors for alcohol use disorder, this method can also test medications being developed to reduce drinking. To begin, connect the ethernet cable from the computer to the pump, and switch on the pump by pressing the gray power on button on the upper right side.
Then press the volume infused"button on the left side while ensuring that the numbers read zero. If the numbers do not read zero, press the clear button. Next, press the options edit"button, and then press the number four to select the computer control option.
Use the arrow buttons on the top row of the pump to select yes and press enter. Then look at the top of the pump screen to ensure that there is a computer control flashing on the screen. Connect the drink button that the participant uses to click for drinks into the USB portal closest to the participant, ensuring that the drink button is connected prior to opening the software or the software will not detect the button.
Insert the dongle, and select the drive to enter the password. Once the password has been accepted, open the drive titled Secu drive"to access the software. Double click the software icon, then click on file and select the option new session"Create a file name using desired participant number, then save the data to the desktop, not the dongle, as the software may overload the dongle and crash.
Select the PR experiment from the dropdown menu labeled select experiment"When the setup screen appears requesting further information on the participant, fill in the fields requesting participant identification number, select standard"as study type, then enter sex and age in the appropriately labeled fields. Enter height in centimeters and weight in kilogram in the required fields using the data collected earlier in the visit, then click on the submit"button. Move the window over the participant's monitor by clicking and dragging across the screen and enlarging to full screen so the participant can see it.
On the laptop, click on the start run"button at the top of the screen. Instruct the participant to press the drink"button as soon as the monitor prompts them to for their four individually standardized priming doses. After collecting the breath alcohol concentration at the 10 minutes mark, enter the breath alcohol concentration into the software by pressing control B and typing in the value to adjust the algorithm if needed.
Allow the participant to rest for 10 minutes. At the 25 minutes mark, inform the participant that the bar is open and include any further instructions required for the experiment. Click the data"tab on the software and select export.
The self-administration variables of peak breath alcohol concentration, total rewards earned, the total number of button presses, and the average rate of button pressing was compared for session one and two. Pearsons are ranged from 0.81 to 0.96 which shows a high test-retest reliability for all self-administration measures. The recent drinking history was closely associated with drinking behaviors in the lab including peak breath alcohol concentration, total ethanol, and system specific measures such as average rate and false button presses fraction.
Subjective responses were analyzed for low and high responders on measures of alcohol expectancies. Low responders reported overall negative expectancies of alcohol at baseline including expectations of cognitive and physical impairment. Subjective response measures during the priming phase revealed that high responders were willing to pay more for their next drink, whereas low responders felt more intoxicated.
During the open bar phase, the high responders reported higher peak scores for liking and wanting alcohol along with a higher peak urge for alcohol. They were willing to pay more for their next drink at the end of the open bar phase. The breath alcohol concentration trajectories revealed that at the 10 minute mark most participants achieved 30 milligrams per deciliter breath alcohol concentration.
Researchers have used this method to examine the effective mediator, such as ghrelin, on alcohol consumption, and examine the relationship between alcohol reward, craving, and seeking behavior.
Overview
This study demonstrates the Progressive-Ratio Computer-assisted Alcohol-Infusion System (CAIS) as a reliable method for examining alcohol self-administration in humans. It captures variability in drinking behavior and assesses risk factors for alcohol use disorder.
Key Study Components
Area of Science
- Neuroscience
- Behavioral Psychology
- Alcohol Research
Background
- The CAIS paradigm allows for the examination of alcohol consumption motivations.
- It can assess risky drinking patterns and their relation to alcohol use disorder.
- Medications aimed at reducing alcohol consumption can be tested using this method.
- Subjective responses to alcohol vary between individuals, influencing consumption behavior.
Purpose of Study
- To validate the CAIS as a sensitive tool for studying alcohol self-administration.
- To explore the relationship between alcohol reward, craving, and seeking behavior.
- To analyze individual differences in alcohol expectancies and responses.
Methods Used
- Participants engage in a progressive ratio task to self-administer alcohol.
- Breath alcohol concentration is measured at intervals during the experiment.
- Data on self-administration variables are collected and analyzed for reliability.
- Subjective responses are assessed to differentiate between low and high responders.
Main Results
- High test-retest reliability was found for self-administration measures.
- Recent drinking history correlated with lab drinking behaviors.
- High responders showed greater willingness to pay for alcohol and reported higher urges.
- Low responders exhibited negative expectancies regarding alcohol effects.
Conclusions
- The CAIS paradigm effectively captures individual differences in alcohol consumption behavior.
- It provides insights into the motivational aspects of alcohol use.
- This method can aid in developing interventions for alcohol use disorder.
Frequently Asked Questions
Executive Industry Relevance
The progressive-ratio intravenous alcohol self-administration paradigm using CAIS provides a robust, quantitative framework for evaluating motivational drivers of alcohol consumption in humans. This approach enables high-confidence assessment of pharmacological interventions targeting reward pathways and supports risk-adjusted decision-making in early-stage neuropsychiatric drug discovery. Its reliability and sensitivity position it as a critical tool for translational research and portfolio triage in addiction therapeutics.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct interrogation of motivational hypotheses underlying substance use disorders.
- Supports functional target validation by quantifying behavioral response to pharmacological modulation.
- Facilitates mechanistic de-risking by linking subjective and objective reward measures.
Screening & Assay Development
- Provides a standardized, reproducible human behavioral assay for candidate evaluation.
- Generates quantitative outputs such as peak BrAC and total rewards earned for cross-study comparison.
- Enables scalable assessment of compound efficacy in modulating reward-driven behaviors.
Translational & Preclinical Research
- Aligns human behavioral phenotypes with preclinical models for improved translational continuity.
- Supports identification of predictive biomarkers related to reward sensitivity and consumption patterns.
- Informs risk-adjusted advancement of candidates targeting motivational circuits.
Pipeline & Workflow Integration
This paradigm bridges early discovery and translational research by providing a validated human model for motivational behavior, supporting lead identification and preclinical validation of CNS-active compounds.
- Discovery Biology: Quantifies motivational response to pharmacological and genetic variables, supporting hypothesis-driven target selection.
- Screening: Delivers reproducible, quantitative behavioral endpoints for compound triage.
- Analytics: Enables statistical comparison of self-administration metrics across interventions and cohorts.
- Translational Research: Facilitates alignment of human and animal model outputs for biomarker discovery.
- Enterprise Reuse: Offers a reusable, standardized platform for ongoing CNS and addiction research programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target engagement and behavioral modulation.
- Operational Value: Enhances standardization, reproducibility, and scalability of human behavioral assays.
- Strategic Value: Improves go/no-go decisions and reduces late-stage attrition in addiction portfolios.
- Portfolio Impact: Supports risk-adjusted prioritization of CNS and addiction therapeutic candidates.
Implementation Considerations
- Requires expertise in human behavioral pharmacology and addiction neuroscience.
- Demands specialized instrumentation for intravenous infusion and BrAC measurement.
- Necessitates rigorous cross-team standardization of protocol and data handling.
- Adaptation to other substance use models may require protocol optimization.
- Participant safety and ethical oversight are critical for human self-administration studies.
